Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8GLS

Complex of human cystic fibrosis transmembrane conductance regulator (CFTR) and Z1834339853

Summary for 8GLS
Entry DOI10.2210/pdb8gls/pdb
EMDB information40207
DescriptorCystic fibrosis transmembrane conductance regulator, human cystic fibrosis transmembrane conductance regulator, MAGNESIUM ION, ... (6 entities in total)
Functional Keywordstransporter, ion channel, transport protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight174975.94
Authors
Liu, F.,Chen, J. (deposition date: 2023-03-23, release date: 2024-06-26, Last modification date: 2025-01-08)
Primary citationLiu, F.,Kaplan, A.L.,Levring, J.,Einsiedel, J.,Tiedt, S.,Distler, K.,Omattage, N.S.,Kondratov, I.S.,Moroz, Y.S.,Pietz, H.L.,Irwin, J.J.,Gmeiner, P.,Shoichet, B.K.,Chen, J.
Structure-based discovery of CFTR potentiators and inhibitors.
Cell, 187:3712-3725.e34, 2024
Cited by
PubMed Abstract: The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, whereas its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available. However, the only potentiator, ivacaftor, has suboptimal pharmacokinetics and inhibitors have yet to be clinically developed. Here, we combine molecular docking, electrophysiology, cryo-EM, and medicinal chemistry to identify CFTR modulators. We docked ∼155 million molecules into the potentiator site on CFTR, synthesized 53 test ligands, and used structure-based optimization to identify candidate modulators. This approach uncovered mid-nanomolar potentiators, as well as inhibitors, that bind to the same allosteric site. These molecules represent potential leads for the development of more effective drugs for cystic fibrosis and secretory diarrhea, demonstrating the feasibility of large-scale docking for ion channel drug discovery.
PubMed: 38810646
DOI: 10.1016/j.cell.2024.04.046
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.8 Å)
Structure validation

234136

PDB entries from 2025-04-02

PDB statisticsPDBj update infoContact PDBjnumon